Los Angeles Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.4K | Buy |
+12,570
| New | +$63.4K | ﹤0.01% | 1287 |
|
|
2025
Q1 | – | Sell |
-13,560
| Closed | -$99.5K | – | 1236 |
|
|
2024
Q4 | $99.5K | Sell |
13,560
-20
| -0.1% | -$147 | ﹤0.01% | 1086 |
|
|
2024
Q3 | $102K | Buy |
13,580
+249
| +2% | +$1.87K | ﹤0.01% | 1142 |
|
|
2024
Q2 | $119K | Buy |
+13,331
| New | +$119K | ﹤0.01% | 1151 |
|
|
2023
Q2 | – | Sell |
-23,257
| Closed | -$541K | – | 1300 |
|
|
2023
Q1 | $541K | Sell |
23,257
-39,668
| -63% | -$923K | ﹤0.01% | 835 |
|
|
2022
Q4 | $1.59M | Sell |
62,925
-949
| -1% | -$24K | 0.01% | 577 |
|
|
2022
Q3 | $1.23M | Buy |
63,874
+48,414
| +313% | +$933K | 0.01% | 628 |
|
|
2022
Q2 | $394K | Sell |
15,460
-24,689
| -61% | -$629K | ﹤0.01% | 1056 |
|
|
2022
Q1 | $1.03M | Buy |
40,149
+22,397
| +126% | +$576K | ﹤0.01% | 744 |
|
|
2021
Q4 | $743K | Buy |
17,752
+6,581
| +59% | +$275K | ﹤0.01% | 834 |
|
|
2021
Q3 | $486K | Buy |
11,171
+10
| +0.1% | +$435 | ﹤0.01% | 1052 |
|
|
2021
Q2 | $528K | Sell |
11,161
-600
| -5% | -$28.4K | ﹤0.01% | 1144 |
|
|
2021
Q1 | $603K | Sell |
11,761
-13,353
| -53% | -$685K | ﹤0.01% | 1128 |
|
|
2020
Q4 | $673K | Buy |
25,114
+12,036
| +92% | +$323K | ﹤0.01% | 1090 |
|
|
2020
Q3 | $449K | Buy |
+13,078
| New | +$449K | ﹤0.01% | 1124 |
|